Identification of amino acid residues important for ligand binding to Fas
G C Starling1, J Bajorath, J Emswiler
1Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, Washington 98121, USA.
Abstract:
The interaction of Fas (CD95), a member of the tumor necrosis factor receptor (TNFR) family, and its ligand (FasL) triggers programmed cell death (apoptosis) and is involved in the regulation of immune responses. Although the Fas-FasL interaction is conserved across species barriers, little is currently known about the molecular details of this interaction. Our aim was to identify residues in Fas that are important for ligand binding. With the aid of a Fas molecular model, candidate amino acid residues were selected in the Fas extracellular domain 2 (D2) and D3 and subjected to serine-scanning mutagenesis to produce mutant Fas molecules in the form of Ig fusion proteins. The effects of these mutations on FasL binding was examined by measuring the ability of these proteins to inhibit FasL-mediated apoptosis of Jurkat cells and bind FasL in ELISA and BIAcore assays. Mutation of two amino acids, R86 and R87 (D2), to serine totally abolished the ability of Fas to interact with its ligand, whereas mutants K84S, L90S, E93S (D2), or H126S (D3) showed reduced binding compared with wild-type Fas. Two mutants (K78S and H95S) bound FasL comparably to wild type. Therefore, the binding of FasL involves residues in two domains that correspond to positions critical for ligand binding in other family members (TNFR and CD40) but are conserved between murine and human Fas.
Insights
Identifying key amino acid residues in Fas (CD95) is crucial for understanding its interaction with Fas ligand (FasL). This study pinpoints specific residues in Fas extracellular domains essential for FasL binding and apoptosis signaling.
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- The Fas/FasL pathway is critical for apoptosis and immune regulation.
- Understanding the molecular basis of Fas-FasL interaction is essential for deciphering its biological roles.
Purpose of the Study:
- To identify specific amino acid residues within the Fas extracellular domain crucial for Fas ligand (FasL) binding.
- To elucidate the molecular mechanisms underlying Fas-FasL interaction.
Main Methods:
- Serine-scanning mutagenesis was employed to generate mutant Fas molecules.
- Fas Ig fusion proteins were used to assess FasL binding.
- Assays included inhibition of FasL-mediated apoptosis, ELISA, and BIAcore analysis.
Main Results:
- Mutations R86S and R87S in Fas extracellular domain 2 (D2) completely abolished FasL binding.
- Mutations K84S, L90S, E93S (D2), and H126S (D3) significantly reduced FasL binding.
- Residues R86, R87, K84, L90, E93, and H126 are important for Fas-FasL interaction.
Conclusions:
- Specific residues in Fas extracellular domains D2 and D3 are critical for FasL binding.
- These findings provide insights into the conserved mechanisms of ligand binding within the tumor necrosis factor receptor superfamily.
Related Concept Videos
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
Ligand Binding and Linkage
Intracellular Signaling Affects Focal Adhesions
Some...


